APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valpromide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valpromide Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchValpromide Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Valpromide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Valpromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valpromide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Valpromide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Valpromide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valpromide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valpromide market include Novartis Pharmaceuticals, Beijing Sail Biopharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Hunan Hansen Pharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., China Resources Double-Crane Pharmaceutical Co., Ltd. and Shanxi Luliang Traditional Chinese Medicine Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valpromide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valpromide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valpromide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valpromide market size, projected growth trends, production technologies, key applications, and end-use industries.

Valpromide Segment by Company

Novartis Pharmaceuticals

Beijing Sail Biopharmaceutical Co., Ltd.

Hunan Dino Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

China Resources Double-Crane Pharmaceutical Co., Ltd.

Shanxi Luliang Traditional Chinese Medicine Factory

Valpromide Segment by Type

Pill

Suppository

Capsule

Valpromide Segment by Application

Hospital

Pharmacy

Others

Valpromide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Valpromide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valpromide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valpromide significant trends, drivers, influence factors in global and regions.

6. To analyze Valpromide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valpromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valpromide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valpromide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valpromide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valpromide industry.

Chapter 3: Detailed analysis of Valpromide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valpromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valpromide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valpromide Industry Trends Table 2. Valpromide Industry Drivers Table 3. Valpromide Industry Opportunities and Challenges Table 4. Valpromide Industry Restraints Table 5. Global Valpromide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valpromide Revenue Share by Company (2021-2026) Table 7. Global Valpromide Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Valpromide Sales Volume Share by Company (2021-2026) Table 9. Global Valpromide Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Valpromide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valpromide Key Company Manufacturing Base & Headquarters Table 12. Global Valpromide Company, Product Type & Application Table 13. Global Valpromide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valpromide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pill Table 18. Significant Companies of Suppository Table 19. Significant Companies of Capsule Table 20. Global Valpromide Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Valpromide Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Valpromide Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Valpromide Sales Volume Share by Type (2021-2026) Table 24. Global Valpromide Sales Volume Share by Type (2027-2032) Table 25. Global Valpromide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Valpromide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Valpromide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Valpromide Sales Value Share by Type (2021-2026) Table 29. Global Valpromide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Others Table 33. Global Valpromide Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Valpromide Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Valpromide Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Valpromide Sales Volume Share by Application (2021-2026) Table 37. Global Valpromide Sales Volume Share by Application (2027-2032) Table 38. Global Valpromide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Valpromide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Valpromide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Valpromide Sales Value Share by Application (2021-2026) Table 42. Global Valpromide Sales Value Share by Application (2027-2032) Table 43. Global Valpromide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Valpromide Sales by Region (2021-2026) & (K Units) Table 45. Global Valpromide Sales Market Share by Region (2021-2026) Table 46. Global Valpromide Sales by Region (2027-2032) & (K Units) Table 47. Global Valpromide Sales Market Share by Region (2027-2032) Table 48. Global Valpromide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Valpromide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Valpromide Sales Value Share by Region (2021-2026) Table 51. Global Valpromide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Valpromide Sales Value Share by Region (2027-2032) Table 53. Global Valpromide Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Valpromide Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Valpromide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Valpromide Sales by Country (2021-2026) & (K Units) Table 58. Global Valpromide Sales Market Share by Country (2021-2026) Table 59. Global Valpromide Sales by Country (2027-2032) & (K Units) Table 60. Global Valpromide Sales Market Share by Country (2027-2032) Table 61. Global Valpromide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Valpromide Sales Value Market Share by Country (2021-2026) Table 63. Global Valpromide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Valpromide Sales Value Market Share by Country (2027-2032) Table 65. Novartis Pharmaceuticals Company Information Table 66. Novartis Pharmaceuticals Business Overview Table 67. Novartis Pharmaceuticals Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Pharmaceuticals Valpromide Product Portfolio Table 69. Novartis Pharmaceuticals Recent Development Table 70. Beijing Sail Biopharmaceutical Co., Ltd. Company Information Table 71. Beijing Sail Biopharmaceutical Co., Ltd. Business Overview Table 72. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio Table 74. Beijing Sail Biopharmaceutical Co., Ltd. Recent Development Table 75. Hunan Dino Pharmaceutical Co., Ltd. Company Information Table 76. Hunan Dino Pharmaceutical Co., Ltd. Business Overview Table 77. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 79. Hunan Dino Pharmaceutical Co., Ltd. Recent Development Table 80. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 81. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 82. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 84. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 85. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 86. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 87. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 89. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 90. China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information Table 91. China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview Table 92. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 94. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Development Table 95. Shanxi Luliang Traditional Chinese Medicine Factory Company Information Table 96. Shanxi Luliang Traditional Chinese Medicine Factory Business Overview Table 97. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio Table 99. Shanxi Luliang Traditional Chinese Medicine Factory Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Valpromide Distributors List Table 103. Valpromide Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Valpromide Product Image Figure 2. Global Valpromide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valpromide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valpromide Sales (2021-2032) & (K Units) Figure 5. Global Valpromide Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Valpromide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pill Image Figure 10. Suppository Image Figure 11. Capsule Image Figure 12. Global Valpromide Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Valpromide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Valpromide Sales Volume Share by Type (2021-2032) Figure 15. Global Valpromide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Valpromide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Valpromide Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global Valpromide Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Valpromide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Valpromide Sales Volume Share by Application (2021-2032) Figure 24. Global Valpromide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Valpromide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Valpromide Sales Value Share by Application (2021-2032) Figure 27. Global Valpromide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Valpromide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Valpromide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Valpromide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Valpromide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Valpromide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Valpromide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Valpromide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Valpromide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Valpromide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Valpromide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Valpromide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Valpromide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Valpromide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Valpromide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Valpromide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Valpromide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Valpromide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Valpromide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Suppository
  • Capsule
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Novartis Pharmaceuticals
  • Beijing Sail Biopharmaceutical Co., Ltd.
  • Hunan Dino Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Shanxi Luliang Traditional Chinese Medicine Factory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valpromide Sales Value (2021-2032)
  4. 1.2.2 Global Valpromide Sales Volume (2021-2032)
  5. 1.2.3 Global Valpromide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valpromide Market Dynamics
  1. 2.1 Valpromide Industry Trends
  2. 2.2 Valpromide Industry Drivers
  3. 2.3 Valpromide Industry Opportunities and Challenges
  4. 2.4 Valpromide Industry Restraints
3 Valpromide Market by Company
  1. 3.1 Global Valpromide Company Revenue Ranking in 2025
  2. 3.2 Global Valpromide Revenue by Company (2021-2026)
  3. 3.3 Global Valpromide Sales Volume by Company (2021-2026)
  4. 3.4 Global Valpromide Average Price by Company (2021-2026)
  5. 3.5 Global Valpromide Company Ranking (2024-2026)
  6. 3.6 Global Valpromide Company Manufacturing Base and Headquarters
  7. 3.7 Global Valpromide Company Product Type and Application
  8. 3.8 Global Valpromide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valpromide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valpromide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valpromide Market by Type
  1. 4.1 Valpromide Type Introduction
  2. 4.1.1 Pill
  3. 4.1.2 Suppository
  4. 4.1.3 Capsule
  5. 4.2 Global Valpromide Sales Volume by Type
  6. 4.2.1 Global Valpromide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Valpromide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Valpromide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Valpromide Sales Value by Type
  10. 4.3.1 Global Valpromide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Valpromide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Valpromide Sales Value Share by Type (2021-2032)
5 Valpromide Market by Application
  1. 5.1 Valpromide Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Valpromide Sales Volume by Application
  6. 5.2.1 Global Valpromide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valpromide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Valpromide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Valpromide Sales Value by Application
  10. 5.3.1 Global Valpromide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valpromide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Valpromide Sales Value Share by Application (2021-2032)
6 Valpromide Regional Sales and Value Analysis
  1. 6.1 Global Valpromide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valpromide Sales by Region (2021-2032)
  3. 6.2.1 Global Valpromide Sales by Region: 2021-2026
  4. 6.2.2 Global Valpromide Sales by Region (2027-2032)
  5. 6.3 Global Valpromide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valpromide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valpromide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valpromide Sales Value by Region (2027-2032)
  9. 6.5 Global Valpromide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valpromide Sales Value (2021-2032)
  12. 6.6.2 North America Valpromide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valpromide Sales Value (2021-2032)
  15. 6.7.2 Europe Valpromide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valpromide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valpromide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valpromide Sales Value (2021-2032)
  21. 6.9.2 South America Valpromide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valpromide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valpromide Sales Value Share by Country, 2025 VS 2032
7 Valpromide Country-level Sales and Value Analysis
  1. 7.1 Global Valpromide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valpromide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valpromide Sales by Country (2021-2032)
  4. 7.3.1 Global Valpromide Sales by Country (2021-2026)
  5. 7.3.2 Global Valpromide Sales by Country (2027-2032)
  6. 7.4 Global Valpromide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valpromide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valpromide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valpromide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valpromide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valpromide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valpromide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valpromide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valpromide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valpromide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valpromide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valpromide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valpromide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valpromide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valpromide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valpromide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valpromide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valpromide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valpromide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valpromide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valpromide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valpromide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valpromide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valpromide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valpromide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valpromide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valpromide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valpromide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valpromide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valpromide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valpromide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valpromide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valpromide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valpromide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valpromide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valpromide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valpromide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valpromide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valpromide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valpromide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valpromide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valpromide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valpromide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valpromide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valpromide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valpromide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valpromide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valpromide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valpromide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valpromide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valpromide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valpromide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valpromide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valpromide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valpromide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valpromide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valpromide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valpromide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valpromide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valpromide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valpromide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valpromide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valpromide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valpromide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valpromide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valpromide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valpromide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valpromide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valpromide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valpromide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valpromide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valpromide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valpromide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valpromide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valpromide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valpromide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valpromide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valpromide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valpromide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valpromide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valpromide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valpromide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valpromide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valpromide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valpromide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valpromide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valpromide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis Pharmaceuticals
  2. 8.1.1 Novartis Pharmaceuticals Company Information
  3. 8.1.2 Novartis Pharmaceuticals Business Overview
  4. 8.1.3 Novartis Pharmaceuticals Valpromide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Pharmaceuticals Valpromide Product Portfolio
  6. 8.1.5 Novartis Pharmaceuticals Recent Developments
  7. 8.2 Beijing Sail Biopharmaceutical Co., Ltd.
  8. 8.2.1 Beijing Sail Biopharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Beijing Sail Biopharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio
  12. 8.2.5 Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Hunan Dino Pharmaceutical Co., Ltd.
  14. 8.3.1 Hunan Dino Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Hunan Dino Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  18. 8.3.5 Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Hunan Hansen Pharmaceutical Co., Ltd.
  20. 8.4.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  24. 8.4.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  26. 8.5.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  30. 8.5.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 China Resources Double-Crane Pharmaceutical Co., Ltd.
  32. 8.6.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  36. 8.6.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shanxi Luliang Traditional Chinese Medicine Factory
  38. 8.7.1 Shanxi Luliang Traditional Chinese Medicine Factory Company Information
  39. 8.7.2 Shanxi Luliang Traditional Chinese Medicine Factory Business Overview
  40. 8.7.3 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio
  42. 8.7.5 Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valpromide Value Chain Analysis
  2. 9.1.1 Valpromide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valpromide Sales Mode & Process
  6. 9.2 Valpromide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valpromide Distributors
  9. 9.2.3 Valpromide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst